• About
  • Subscribe
  • Advertise
  • Contact
Monday, January 19, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Call to double Australian medical research funds

by Myles Hume
September 6, 2023
in Eye disease, Local, News, Research
Reading Time: 2 mins read
A A
A report found every dollar not spent on research is $3.32 in economic activity lost.

A report found every dollar not spent on research is $3.32 in economic activity lost.

Share on FacebookShare on Twitter

The Australian Universities Accord Panel is expected to recommend setting a bold research and development investment target of 3% of GDP by 2035, and a doubling of the Australian Research Council (ARC), National Health and Medical Research Council (NHMRC), and university Research Block Grants funding from 2024 in its final report.

“These two powerful recommendations will seize Australia’s share of the new jobs, income and industries that will be generated by major economy-powering research breakthroughs over the next decade,” said Science and Technology Australia (STA) CEO Misha Schubert.

“Australia’s future economic firepower relies on the Accord Panel making these recommendations in its final report to the government.”

These funding sources, particularly in the NHMRC, often support vital eye research in institutions across Australia.

In its submission to the Australian Universities Accord Interim Report, Science and Technology Australia has called for an urgent, medium, and long-term plan for a major uplift in economy-boosting research funding.

“Without a clear recommendation from the Accord Panel for a bold R&D uplift, the Australian Government won’t have the policy and budget levers it needs to deepen Australia’s investment,” said Schubert.

“The ARC’s report this week highlighted the cost of not investing in research — every dollar not spent on research is $3.32 in economic activity lost.”

As the nation’s peak body for science and technology, STA has urged the panel to recommend an official research and development investment target for Australia, with an interim target of 2.4% by 2030, plus develop an investment roadmap to reach the target.

It has also advised the panel to start a major scale up in university research investments from 2024 by doubling Australia’s investments in the ARC and NHMRC’s competitive grants budgets and university Research Block Grants.

“If we set an R&D investment target and boost grants budgets now, Australia can seize the wealth, jobs, opportunities, and inventions of tomorrow. If we miss our moment in history, we consign ourselves to the slow lane on the highway to a future economy,” Schubert said.

“We call on the panel to be bold, clear and ambitious in its R&D recommendations to Government, so the Australian Government has a roadmap to protect Australian jobs, incomes and living standards.”

More reading

The rocky path of an early career researcher

Future Vision Foundation: a platform for next-generation eye researchers

AI offers ‘comparable’ advice to ophthalmologists

Related Posts

IOLs were stored on the International Space Station and exposed to space conditions for six months. Image: Lemdah/stock.adobe.com.

Intraocular lenses sent to space in first-of-its-kind research project

by Staff Writer
January 19, 2026

A research collaboration between the John A. Moran Eye Center’s Intermountain Ocular Research Center (IORC) and cataract surgeon Dr Morgan...

Marcolin is the owner of a number of luxury eyewear brands. Image: Marcolin.

VSP Vision acquires global eyewear company Marcolin

by Staff Writer
January 19, 2026

American firm VSP Vision has completed the acquisition of global eyewear designer and manufacturer Marcolin from PAI Partners and other...

The study concluded that clinicians should be aware of how cognitive limitations can lead to a reliance on "decisional shortcuts" that might bias decision-making. Image: rh2010/stock.adobe.com

Study supports rethink of IOP threshold in glaucoma treatment

by Staff Writer
January 16, 2026

New research has revealed that despite an evolving clinical understanding of glaucoma, many ophthalmologists continue to rely on the historical...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited